These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37874837)

  • 61. Antimicrobial resistance, molecular characteristics, virulence and pathogenicity of
    Yu Y; Dai P; Niu M; Han R; Liu S; Du Y
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37389571
    [No Abstract]   [Full Text] [Related]  

  • 62. Isolation, characterization and efficacy of phage MJ2 against biofilm forming multi-drug resistant Enterobacter cloacae.
    Jamal M; Andleeb S; Jalil F; Imran M; Nawaz MA; Hussain T; Ali M; Ur Rahman S; Das CR
    Folia Microbiol (Praha); 2019 Jan; 64(1):101-111. PubMed ID: 30090964
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
    Goessens WH; Mouton JW; ten Kate MT; Bijl AJ; Ott A; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Mar; 59(3):507-16. PubMed ID: 17289765
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of an New Delhi-Metallo-1-Producing
    Xue M; Wang K; Lu L; Li Z; Li P; Li J; Lin Y; Yang L; Qi K; Song H; Li P
    Microb Drug Resist; 2021 May; 27(5):706-709. PubMed ID: 33090069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Functional Annotation of Hypothetical Proteins From the
    Dey S; Shahrear S; Afroj Zinnia M; Tajwar A; Islam ABMMK
    Bioinform Biol Insights; 2022; 16():11779322221115535. PubMed ID: 35958299
    [No Abstract]   [Full Text] [Related]  

  • 66. In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic gram-negative bacilli.
    Chong Y; Lee K; Kwon OH
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():21-9. PubMed ID: 8150765
    [TBL] [Abstract][Full Text] [Related]  

  • 67.
    Gu M; Werlinger P; Cho JH; Jang N; Choi SS; Suh JW; Cheng J
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613723
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.
    Veleba M; De Majumdar S; Hornsey M; Woodford N; Schneiders T
    J Antimicrob Chemother; 2013 May; 68(5):1011-8. PubMed ID: 23349441
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The cyclohexane tolerance and Phe-Arg-β-naphtylamide susceptibility of multidrug-resistant Enterobacter cloacae clinical isolates, and the predominance of one PFGE clone in Hungary.
    Glatz K; Tóth A; Pászti J
    Clin Microbiol Infect; 2011 Aug; 17(8):1254-61. PubMed ID: 21029248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Complete genome sequence of Enterobacter cloacae subsp. cloacae type strain ATCC 13047.
    Ren Y; Ren Y; Zhou Z; Guo X; Li Y; Feng L; Wang L
    J Bacteriol; 2010 May; 192(9):2463-4. PubMed ID: 20207761
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum beta-lactamase.
    Fernández A; Pereira MJ; Suárez JM; Poza M; Treviño M; Villalón P; Sáez-Nieto JA; Regueiro BJ; Villanueva R; Bou G
    J Clin Microbiol; 2011 Mar; 49(3):822-8. PubMed ID: 21227991
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Localization of cephalosporinase in Enterobacter cloacae by immunocytochemical examination.
    Ishii Y; Ichikawa M; Yamaguchi K; Takano K; Inoue M
    J Antibiot (Tokyo); 1991 Oct; 44(10):1088-95. PubMed ID: 1955391
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Colistin resistance in Enterobacter spp. isolates in Korea.
    Hong YK; Lee JY; Ko KS
    J Microbiol; 2018 Jun; 56(6):435-440. PubMed ID: 29858832
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The dissemination mode of drug-resistant genes in Enterobacter cloacae.
    Liu J; Zeng T; Su G; Lin LY; Zhao Y; Yang WQ; Xie WX; Zhao ZG; Li GM
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():87-92. PubMed ID: 25657163
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enterobacter cloacae infection characteristics and outcomes in battlefield trauma patients.
    Bennett W; Mende K; Campbell WR; Beckius M; Stewart L; Shaikh F; Rahman A; Tribble DR; Yabes JM
    PLoS One; 2023; 18(8):e0290735. PubMed ID: 37643169
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Amaranthus caudatus extract inhibits the invasion of E. coli into uroepithelial cells.
    Mohanty S; Zambrana S; Dieulouard S; Kamolvit W; Nilsén V; Gonzales E; Östenson CG; Brauner A
    J Ethnopharmacol; 2018 Jun; 220():155-158. PubMed ID: 29621584
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Invasion of rabbit ileal tissue by Enterobacter cloacae varies with the concentration of OmpX in the outer membrane.
    de Kort G; Bolton A; Martin G; Stephen J; van de Klundert JA
    Infect Immun; 1994 Nov; 62(11):4722-6. PubMed ID: 7927747
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structural investigation of a polysaccharide from the mycelium of Enterobacter cloacae and its antibacterial activity against extensively drug-resistant E. cloacae producing SHV-12 extended-spectrum β-lactamase.
    Liu J; Xu Z; Guo Z; Zhao Z; Zhao Y; Wang X
    Carbohydr Polym; 2018 Sep; 195():444-452. PubMed ID: 29804997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.